To address long-term effects of a transient inhibition of iNOS and/or anti-CD18/CD49d administration, we simulated a 3-day inhibition of monocyte activation and/or blocked cell recruitment and modeled the subsequent 3 weeks of infection (Figure 6F). The gene discussed is ITGB2; the disease is infection.